The First Shall (Be) Last: Understanding Durable T Cell Responses in Immunotherapy

Immunity - United States
doi 10.1016/j.immuni.2018.12.029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Durable Responses After CD19-targeted CAR-T Cell Immunotherapy With Concurrent Ibrutinib for CLL After Prior Ibrutinib Failure

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Adjuvant-Enhanced CD4 T Cell Responses Are Critical to Durable Vaccine Immunity

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Soluble Γc Receptor Attenuates Anti-Tumor Responses of CD8+ T Cells in T Cell Immunotherapy

International Journal of Cancer
Cancer ResearchOncology
2018English

Will the Last Be First and the First Last? The Role of Classroom Registers in Cognitive Skill Acquisition

PLoS ONE
Multidisciplinary
2018English

Antileukemic T-Cell Responses Can Be Predicted by the Composition of Specific Regulatory T-Cell Subpopulations

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2013English

Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

Enhanced Local and Systemic Anti-Melanoma CD8+ T Cell Responses After Memory T Cell-Based Adoptive Immunotherapy in Mice

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2016English

Specific Immunotherapy Modifies Allergen-Specific CD4+ T-Cell Responses in an Epitope-Dependent Manner

Journal of Allergy and Clinical Immunology
AllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy